LT3004B - Profilaktine priemone pries vezinius susirgimus - Google Patents
Profilaktine priemone pries vezinius susirgimus Download PDFInfo
- Publication number
- LT3004B LT3004B LTIP120A LTIP120A LT3004B LT 3004 B LT3004 B LT 3004B LT IP120 A LTIP120 A LT IP120A LT IP120 A LTIP120 A LT IP120A LT 3004 B LT3004 B LT 3004B
- Authority
- LT
- Lithuania
- Prior art keywords
- mead
- growth
- spleen
- drinks
- dose
- Prior art date
Links
- 230000003449 preventive effect Effects 0.000 title claims abstract description 7
- 206010028980 Neoplasm Diseases 0.000 title claims description 14
- 201000011510 cancer Diseases 0.000 title claims description 9
- 235000019988 mead Nutrition 0.000 abstract description 16
- 210000000952 spleen Anatomy 0.000 abstract description 15
- 230000012010 growth Effects 0.000 abstract description 10
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 206010039491 Sarcoma Diseases 0.000 abstract description 3
- 230000001093 anti-cancer Effects 0.000 abstract description 3
- 201000005296 lung carcinoma Diseases 0.000 abstract description 3
- 241000700159 Rattus Species 0.000 description 11
- 230000004614 tumor growth Effects 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 240000002234 Allium sativum Species 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 201000000274 Carcinosarcoma Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000016622 Filipendula ulmaria Nutrition 0.000 description 1
- 244000061544 Filipendula vulgaris Species 0.000 description 1
- 239000006000 Garlic extract Substances 0.000 description 1
- 244000207740 Lemna minor Species 0.000 description 1
- 235000006439 Lemna minor Nutrition 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 1
- 241000819999 Nymphes Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 201000010897 colon adenocarcinoma Diseases 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000668 effect on calcium Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000020706 garlic extract Nutrition 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 208000003747 lymphoid leukemia Diseases 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Claims (1)
- IŠRADIMO APIBRĖŽTISMidaus Stakliškės arba Bočiai panaudojimas kaip profilaktinės priemonės prieš vėžinius susirgimus.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LTIP120A LT3004B (lt) | 1992-09-09 | 1992-09-09 | Profilaktine priemone pries vezinius susirgimus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LTIP120A LT3004B (lt) | 1992-09-09 | 1992-09-09 | Profilaktine priemone pries vezinius susirgimus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LTIP120A LTIP120A (lt) | 1994-03-25 |
| LT3004B true LT3004B (lt) | 1994-08-25 |
Family
ID=19721047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTIP120A LT3004B (lt) | 1992-09-09 | 1992-09-09 | Profilaktine priemone pries vezinius susirgimus |
Country Status (1)
| Country | Link |
|---|---|
| LT (1) | LT3004B (lt) |
-
1992
- 1992-09-09 LT LTIP120A patent/LT3004B/lt unknown
Non-Patent Citations (3)
| Title |
|---|
| L. SKLIAREVSKIS: "Maistinės augalų gydomosios savybės" |
| LIETUVOS MA DARBAI: "Ser C 71" |
| TARYBŲ LIETUVOS ENCIKLOPEDIJA: "Tarybų Lietuvos enciklopedija" |
Also Published As
| Publication number | Publication date |
|---|---|
| LTIP120A (lt) | 1994-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shashkina et al. | Chemical and medicobiological properties of chaga | |
| Dashwood et al. | Chemopreventive properties of chlorophyllin: inhibition of aflatoxin B1 (AFB1)-DNA binding in vivo and anti-mutagenic activity against AFB1 and two heterocyclic amines in the Salmonella mutagenicity assay | |
| Bounous et al. | Dietary whey protein inhibits the development of dimethylhydrazine induced malignancy | |
| KR100939147B1 (ko) | Ｎ6-치환된 아데닌을 기본으로 한 헤테로시클릭 화합물,이들의 제조방법, 약물, 화장품 제제 및 성장조절제제조를 위한 이들의 용도, 이들 화합물을 함유하는약제학적 제제, 화장품 제제 및 성장조절제 | |
| MXPA03004455A (es) | Composicion de solucion alcalina, altamente funcional de multiples aplicaciones, preparacion de la misma, y para el uso de un inmunoestimulador no especifico. | |
| US6964785B2 (en) | Herbal composition for improving anticancer activity, immune response and hematopoiesis of the body, and protecting the body from oxidative damage, and the method of preparing the same | |
| KR20100096034A (ko) | 산삼 또는 인삼을 포함한 인삼류의 형성층 유래 식물줄기세포주를 유효성분으로 함유하는 면역증강용 조성물 | |
| Adetutu et al. | Anticlastogenic effects of Hibiscus sabdariffa fruits against sodium arsenite‐induced micronuclei formation in erythrocytes in mouse bone marrow | |
| Markkula et al. | Effects of Short‐and Long‐term Ultraviolet B Irradiation on the Immune System of the Common Carp (Cyprinus carpio)¶ | |
| CN113262229B (zh) | 诸葛菜碱d在制备抗辐射损伤的药物中的应用 | |
| Mladenović et al. | Determination of the content of bioactive components in different extracts of Portulaca oleracea L | |
| LT3004B (lt) | Profilaktine priemone pries vezinius susirgimus | |
| Mozdarani | Radioprotective Properties of Histamine H 2 Receptor Antagonists: present and future prospects | |
| Khaghanzadeh et al. | Umbelliprenin induced both anti-inflammatory and regulatory cytokines in C57/BL6 mice | |
| Schrauzer et al. | Effects of dietary selenium and of lead on the genesis of spontaneous mammary tumors in mice | |
| Ting et al. | Host control of tumor growth | |
| Thomas et al. | The immune response in cirrhotic rats. Antigen distribution, humoral immunity, cell-mediated immunity and splenic suppressor cell activity | |
| Milas et al. | Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2 | |
| Shabad et al. | Transplacental and combined long‐term effect of DDT in five generations of A‐strain mice | |
| Stoewsand et al. | Toxicologic response in mice fed Cucurbita fruit | |
| DE19901732A1 (de) | Mittel mit Antitumorwirkung und dessen Verwendung | |
| KR100518214B1 (ko) | 항암제, 면역기능강화제 및 간기능 강화제용 초석잠 추출물을 포함하는 조성물 | |
| AU2017215340A1 (en) | Antioxidants against oxidative stress during a stressor event | |
| CN106619596B (zh) | 阿替匹林c在制备预防和治疗放疗损伤药物中的应用 | |
| Naumov et al. | Radioprotective properties of selenomethionine with methionine, extracts from Basidium Fungi and exogenous DNA |